At what price?
- PMID: 17851515
- DOI: 10.1038/449176a
At what price?
Similar articles
-
The path to new medicines.Nature. 2007 Sep 13;449(7159):164-5. doi: 10.1038/449164a. Nature. 2007. PMID: 17851511 No abstract available.
-
A prescription for drug delivery.Nature. 2007 Sep 13;449(7159):170-2. doi: 10.1038/449170a. Nature. 2007. PMID: 17851513 No abstract available.
-
The road to recovery.Nature. 2007 Sep 13;449(7159):180-2. doi: 10.1038/449180a. Nature. 2007. PMID: 17851516 No abstract available.
-
Orphan drug development across Europe: bottlenecks and opportunities.Drug Discov Today. 2008 Aug;13(15-16):670-6. doi: 10.1016/j.drudis.2008.05.001. Epub 2008 Jun 24. Drug Discov Today. 2008. PMID: 18583178 Review.
-
The concept of essential medicines: lessons for rich countries.BMJ. 2004 Nov 13;329(7475):1169-72. doi: 10.1136/bmj.329.7475.1169. BMJ. 2004. PMID: 15539676 Free PMC article. Review.
Cited by
-
Orphan drugs for rare diseases: is it time to revisit their special market access status?Drugs. 2012 Jul 30;72(11):1437-43. doi: 10.2165/11635320-000000000-00000. Drugs. 2012. PMID: 22747423
-
Unintended effects of orphan product designation for rare neurological diseases.Ann Neurol. 2012 Oct;72(4):481-90. doi: 10.1002/ana.23672. Ann Neurol. 2012. PMID: 23109143 Free PMC article. Review.
-
Debates over orphan drug pricing: a meta-narrative literature review.Orphanet J Rare Dis. 2025 Mar 7;20(1):107. doi: 10.1186/s13023-025-03634-2. Orphanet J Rare Dis. 2025. PMID: 40055799 Free PMC article. Review.
-
Cost-effectiveness of miglustat versus symptomatic therapy of Niemann-Pick disease type C.Int J Clin Pharm. 2022 Dec;44(6):1442-1453. doi: 10.1007/s11096-022-01491-8. Epub 2022 Oct 15. Int J Clin Pharm. 2022. PMID: 36243834
-
Cost-effectiveness of inguinal hernia surgery in northwestern Ecuador.World J Surg. 2013 Jan;37(1):32-41. doi: 10.1007/s00268-012-1808-5. World J Surg. 2013. PMID: 23073503
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical